Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F207CEB7.svg?ark=w1%2F20260515%2FF207CEB7)](https://nobleid.org/work/w1/20260515/F207CEB7)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors